Literature DB >> 19929911

Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum.

Andrea N Ortiz1, Benjamin J Kurth, Gregory L Osterhaus, Michael A Johnson.   

Abstract

Huntington's disease (HD) is a fatal, neurodegenerative movement disorder characterized by preferential and extensive striatal degeneration. Here, we used fast-scan cyclic voltammetry to study the mobilization and efflux of reserve pool dopamine (DA) in striatal brain slices from HD model R6/2 mice. When applying stimulus trains of 120 pulses, evoked DA release in wild-type (WT) slices was greater than that in R6/2 slices at the higher frequencies (50 and 60 Hz). To quantify cytosolic and reserve pool DA levels, amphetamine-induced DA efflux was measured after pre-treatment with either tetrabenazine or alpha-methyl-p-tyrosine. Slices from 12-week-old R6/2 mice released less DA than slices from WT mice, while no difference was noted in slices from 6-week old mice. The vesicular release of reserve pool DA, mobilized by treatment with cocaine, was shorter lived in R6/2 slices compared with WT slices even though peak DA release was the same. Moreover, the number of DA reserve pool vesicles in R6/2 mice was less than half of that in WT. Therefore, our data suggest that the same number of DA molecules are present in each reserve pool vesicle in WT and R6/2 mice and that these vesicles are readily mobilized in both genotypes; however, R6/2 mice have fewer DA reserve pool vesicles available for mobilization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19929911      PMCID: PMC3999965          DOI: 10.1111/j.1471-4159.2009.06501.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  38 in total

1.  Visualizing recycling synaptic vesicles in hippocampal neurons by FM 1-43 photoconversion.

Authors:  N Harata; T A Ryan; S J Smith; J Buchanan; R W Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

2.  Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice.

Authors:  A Petersén; Z Puschban; J Lotharius; B NicNiocaill; P Wiekop; W T O'Connor; P Brundin
Journal:  Neurobiol Dis       Date:  2002-10       Impact factor: 5.996

Review 3.  Short-term synaptic plasticity.

Authors:  Robert S Zucker; Wade G Regehr
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

4.  Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2.

Authors:  Marat V Avshalumov; Billy T Chen; Sarah P Marshall; Dianna M Peña; Margaret E Rice
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

5.  Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum.

Authors:  N V Kulagina; M J Zigmond; A C Michael
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

6.  Dopamine release from pharmacologically distinct storage pools in rat striatum following stimulation at frequency of neuronal bursting.

Authors:  L Yavich; E MacDonald
Journal:  Brain Res       Date:  2000-07-07       Impact factor: 3.252

7.  Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease.

Authors:  A J Morton; R L Faull; J M Edwardson
Journal:  Brain Res Bull       Date:  2001-09-15       Impact factor: 4.077

8.  Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice.

Authors:  Christopher A Meade; Yun-Ping Deng; Francesca R Fusco; Nobel Del Mar; Steven Hersch; Dan Goldowitz; Anton Reiner
Journal:  J Comp Neurol       Date:  2002-07-29       Impact factor: 3.215

Review 9.  Two synaptic vesicle pools, vesicle recruitment and replenishment of pools at the Drosophila neuromuscular junction.

Authors:  Hiroshi Kuromi; Yoshi Kidokoro
Journal:  J Neurocytol       Date:  2003 Jun-Sep

10.  The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease.

Authors:  Miriam A Hickey; Gavin P Reynolds; A Jennifer Morton
Journal:  J Neurochem       Date:  2002-04       Impact factor: 5.372

View more
  28 in total

1.  Differential electrophysiological changes in striatal output neurons in Huntington's disease.

Authors:  Véronique M André; Carlos Cepeda; Yvette E Fisher; My Huynh; Nora Bardakjian; Sumedha Singh; X William Yang; Michael S Levine
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

Review 2.  The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease.

Authors:  Ignacio Munoz-Sanjuan; Gillian P Bates
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

3.  Ex Vivo Measurement of Electrically Evoked Dopamine Release in Zebrafish Whole Brain.

Authors:  Mimi Shin; Thomas M Field; Chase S Stucky; Mia N Furgurson; Michael A Johnson
Journal:  ACS Chem Neurosci       Date:  2017-06-28       Impact factor: 4.418

4.  Regional differences in dopamine release in the R6/2 mouse caudate putamen.

Authors:  Sam V Kaplan; Ryan A Limbocker; Beth Levant; Michael A Johnson
Journal:  Electroanalysis       Date:  2018-03-30       Impact factor: 3.223

5.  5-Fluorouracil impairs attention and dopamine release in rats.

Authors:  David P Jarmolowicz; Rachel Gehringer; Shea M Lemley; Michael J Sofis; Sam Kaplan; Michael A Johnson
Journal:  Behav Brain Res       Date:  2019-01-07       Impact factor: 3.332

6.  Measurement of Total Antioxidant Capacity in Sub-μL Blood Samples Using Craft Paper-based Analytical Devices.

Authors:  Meng Sun; Michael A Johnson
Journal:  RSC Adv       Date:  2015-06-18       Impact factor: 3.361

7.  LC-MS/MS quantification of salvinorin A from biological fluids.

Authors:  Michael J Caspers; Todd D Williams; Kimberly M Lovell; Anthony Lozama; Eduardo R Butelman; Mary Jeanne Kreek; Matthew Johnson; Roland Griffiths; Katherine Maclean; Thomas E Prisinzano
Journal:  Anal Methods       Date:  2013-12-21       Impact factor: 2.896

8.  Electrochemical Measurement of Dopamine Release and Uptake in Zebrafish Following Treatment with Carboplatin.

Authors:  Thomas M Field; Mimi Shin; Chase S Stucky; Joseph Loomis; Michael A Johnson
Journal:  Chemphyschem       Date:  2018-04-25       Impact factor: 3.102

9.  Dopamine Release and Uptake Impairments and Behavioral Alterations Observed in Mice that Model Fragile X Mental Retardation Syndrome.

Authors:  Jenny L Fulks; Bliss E O'Bryhim; Sara K Wenzel; Stephen C Fowler; Elena Vorontsova; Jonathan W Pinkston; Andrea N Ortiz; Michael A Johnson
Journal:  ACS Chem Neurosci       Date:  2010-10-20       Impact factor: 4.418

Review 10.  The role of dopamine in Huntington's disease.

Authors:  Carlos Cepeda; Kerry P S Murphy; Martin Parent; Michael S Levine
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.